About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tnnt2+
wild type
MGI:2433258
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Tnnt2tm2.1Feah/Tnnt2+ involves: 129S6/SvEvTac * FVB/N MGI:5910772
ht2
Tnnt2tm1Mmto/Tnnt2+ involves: 129S/SvEv MGI:3821723
ht3
Tnnt2tm2Mmto/Tnnt2+ involves: 129S/SvEv * C57BL/6 MGI:3804499
cx4
Plntm1Egk/Plntm1Egk
Tnnt2tm2.1Feah/Tnnt2+
involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N MGI:5910773
cx5
Tg(Myh6-Tnnt2*)1Feah/0
Tnnt2tm1Feah/Tnnt2+
involves: 129S/SvEv * 129S6/SvEvTac * FVB/N MGI:3805039


Genotype
MGI:5910772
ht1
Allelic
Composition
Tnnt2tm2.1Feah/Tnnt2+
Genetic
Background
involves: 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tnnt2tm2.1Feah mutation (0 available); any Tnnt2 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice exhibit poor survival, with females showing better survival rates than males
• mice exhibit poor survival, with females showing better survival rates than males

cardiovascular system
• increase in left ventricular end diastolic diameter indicating left ventricle dilation
• the Hill coefficient is decreased in hearts, implying decreased cooperativity in muscle force generation
• 54% and 20% increases, respectively, in peak systolic and end diastolic intracellular calcium concentrations in 8 week old hearts
• hearts show a prolonged systolic rise and diastolic fall in calcium concentrations
• dilated cardiomyopathy is evident at 6 weeks of age and persists at 12 and 30 weeks of age
• however, no myofibrillar disarray, fibrosis or apoptosis is seen in 16 week old mice
• decrease in fractional shorting indicating reduced systolic function
• echocardiography shows increases in left ventricular end diastolic diameter and left ventricular end systolic diameter and decreases in fractional shorting in both males and females at 6, 12, and 30 weeks of age
• hearts exhibit a slower intrinsic sinus rhythm heart rate
• hearts exhibit lower peak heart rates in response to beta-adrenergic stimulation with isoproterenol and exposure to higher isoproterenol levels leads to sustained dysrhythmias
• 2 of 4 mice exhibit nonsustainable polymorphic ventricular tachyarrhythmia on aggressive programmed ventricular stimulation
• skinned fibers from hearts show reduced myofilament calcium sensitivity, without any changes in maximally activated force or length-dependent changes in calcium sensitivity

muscle
• dilated cardiomyopathy is evident at 6 weeks of age and persists at 12 and 30 weeks of age
• however, no myofibrillar disarray, fibrosis or apoptosis is seen in 16 week old mice
• decrease in fractional shorting indicating reduced systolic function

nervous system
• action potential durations are shorter in hearts

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy 1D DOID:0110426 OMIM:601494
J:243725




Genotype
MGI:3821723
ht2
Allelic
Composition
Tnnt2tm1Mmto/Tnnt2+
Genetic
Background
involves: 129S/SvEv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tnnt2tm1Mmto mutation (1 available); any Tnnt2 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• despite most causative mutations in TNNT2 resulting in cardiomyopathy in humans being dominant, heterozygous mice are viable with normal heart structure and function

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
NOT dilated cardiomyopathy 1D DOID:0110426 OMIM:601494
J:141967




Genotype
MGI:3804499
ht3
Allelic
Composition
Tnnt2tm2Mmto/Tnnt2+
Genetic
Background
involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tnnt2tm2Mmto mutation (0 available); any Tnnt2 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• high incidence of sudden death in mice particularly between 1 and 3 months of age
• mice die after developing repetitive Torsade des Pointes which degenerates into ventricular defibrillation
• treatment with pimobendan, a Ca2+ sensitizer increases life span

cardiovascular system
• increase in size is greater in homozygotes compared to heterozygotes
• treatment with pimobendan, a Ca2+ sensitizer decreases heart size
• increase in left ventricular end-diastolic dimension
• however, no significant differences in wall thickness are detected
• markers of heart failure are significantly increased at 3 and 5 but not at 2 months of age
• significant reduction in left ventricular ejection fraction
• lower left ventricular end-systolic pressure after administration of isoproterenol
• but, no significant difference in blood pressure of heart rate
• electrophysiological abnormalities with long QT
• decrease in Ca2+ sensitivity of force generation with a reduced pCa value at half-maximal force generation
• faster peak rates of increase and decrease in cytoplasmic Ca2+ in intact fibers compared to wild-type controls
• significant increase in cardiomyocyte apoptosis
• differences are larger in homozygotes compared to heterozygotes
• however, maximum force-generating capabilities and Hill coefficient values are not different from controls and intact fibers show no significant decrease in maximum isometric force per cross-sectional area

muscle
• significant reduction in left ventricular ejection fraction

growth/size/body
• increase in size is greater in homozygotes compared to heterozygotes
• treatment with pimobendan, a Ca2+ sensitizer decreases heart size

cellular

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy 1D DOID:0110426 OMIM:601494
J:137784




Genotype
MGI:5910773
cx4
Allelic
Composition
Plntm1Egk/Plntm1Egk
Tnnt2tm2.1Feah/Tnnt2+
Genetic
Background
involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plntm1Egk mutation (7 available); any Pln mutation (16 available)
Tnnt2tm2.1Feah mutation (0 available); any Tnnt2 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• mice exhibit left ventricular dilatation
• dilated cardiomyopathy is similar to that seen in single Tnnt2 heterozygotes
• mice exhibit decreased fractional shortening

muscle
• dilated cardiomyopathy is similar to that seen in single Tnnt2 heterozygotes
• mice exhibit decreased fractional shortening




Genotype
MGI:3805039
cx5
Allelic
Composition
Tg(Myh6-Tnnt2*)1Feah/0
Tnnt2tm1Feah/Tnnt2+
Genetic
Background
involves: 129S/SvEv * 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Myh6-Tnnt2*)1Feah mutation (0 available)
Tnnt2tm1Feah mutation (0 available); any Tnnt2 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• massive
• mice exhibit severe dilated cardiomyopathy
• left ventricular end diastolic diameter is increased compared to in heterozygous mice with a wild-type transgene
• non-sustained tachycardia was induced in 2 of 5 mice compared to only 1 of 10 wild-type mice
• mice exhibit myofiber calcium desensitization
• evident by molecular markers

muscle
• mice exhibit severe dilated cardiomyopathy
• left ventricular end diastolic diameter is increased compared to in heterozygous mice with a wild-type transgene





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/25/2025
MGI 6.24
The Jackson Laboratory